INS and metabolic dysfunction-associated steatotic liver disease: Insulin resistance (IR), characterized by reduced responsiveness of peripheral tissues to insulin, represents a pivotal pathophysiological phenotype in metabolic syndrome, such as hypertension, dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and type 2 diabetes (T2D; Beale, 2013).